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Background: Alcohol dependence is a complex psychological disorder whose phenome-
nology changes as the disorder progresses. Neuroscience has provided a variety of theories
and evidence for the development, maintenance, and severity of addiction; however,
clinically, it has been difficult to evaluate alcohol use disorder (AUD) severity.
Objective: This study seeks to evaluate and validate a data-driven approach to capturing
alcohol severity in a community sample.
Method: Participants were non-treatment seeking problem drinkers (n=283). A struc-
tural equation modeling approach was used to (a) verify the latent factor structure of the
indices of AUD severity; and (b) test the relationship between the AUD severity factor and
measures of alcohol use, affective symptoms, and motivation to change drinking.
Results: The model was found to fit well, with all chosen indices of AUD severity load-
ing significantly and positively onto the severity factor. In addition, the paths from the
alcohol use, motivation, and affective factors accounted for 68% of the variance in AUD
severity. Greater AUD severity was associated with greater alcohol use, increased affective
symptoms, and higher motivation to change.
Conclusion: Unlike the categorical diagnostic criteria, the AUD severity factor is com-
prised of multiple quantitative dimensions of impairment observed across the progression
of the disorder. The AUD severity factor was validated by testing it in relation to other
outcomes such as alcohol use, affective symptoms, and motivation for change. Clinically,
this approach to AUD severity can be used to inform treatment planning and ultimately to
improve outcomes.
Keywords: alcohol use disorder severity, structural equation modeling, alcoholism, DSM-IV-TR symptom count,
affective symptoms, motivation to change
INTRODUCTION
Alcohol dependence is a complex psychological disorder char-
acterized by excessive and compulsive alcohol use, the develop-
ment of tolerance and withdrawal, and overall functional impair-
ment [American Psychiatric (1)]. Traditionally, alcohol abuse and
dependence have been conceptualized as categorical, that is, either
a patient meets diagnosis or not. However, it remains unclear
whether this all-or-none model is capturing the complete picture
of alcohol use disorder (AUD). Utilizing a categorical construct
makes it difficult to capture the full spectrum of AUDs includ-
ing the multiple problem areas that are associated with excessive
drinking. Examining the full spectrum of AUD severity may elu-
cidate some of the complexities associated with the progressive,
chronic, and relapsing nature of the disorder.
Multiple neurobiological theories have mapped out the pro-
gression from alcohol use to alcohol dependence. One theory
hypothesizes that addiction is the result of the shift from goal-
directed actions to habits and ultimately, to compulsive drug-
seeking and taking (2, 3). This transition from deliberate drug use
to habitual responding has been hypothesized to reflect a shift from
prefrontal cortical activation to striatal regions and from ventral
to dorsal subregions (3). The neuroadaptation associated with the
various stages of addiction may also affect executive control over
behavior, which promotes habit-forming behavior (3). The incen-
tive sensitization theory further proposes that neuroadaptation
occurs during disorder progression in which the brain circuitry
becomes hypersensitive to drugs and drug-associated cues [see
review by Robinson and Berridge (4)], and this hypersensitivity
appears to be persistent for years (5, 6). These theories suggest
meaningful neurobiological adaptations occur across the progres-
sion from alcohol use to alcohol dependence, yet their translation
to clinical samples has been limited at best.
Data to support these theories has come from both preclinical
and human samples. Previous studies found that moderate/heavy
drinkers reported greater stimulant-like effects after acute alcohol
dose as compared to light social drinkers [e.g., (7)]. These findings
suggest that heavy drinkers may be more sensitive to the rewarding
and pleasant effects of alcohol, placing them at greater risk for the
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development of an AUD. Although neurobiological theories and
more recent preclinical findings have led to a better understanding
of the progression of AUD severity, these have yet to be applied
clinically (8). In clinical settings, determining whether or not a
patient meets criteria for AUD does little to inform the necessary
treatment, as the impact on functioning and stage of progression
(i.e., severity) warrant the most clinical attention. In fact, in fol-
lowing the current DSM-IV diagnostic criteria, some patients may
only meet criteria for one or two out of the four symptoms of
dependence and none of the three symptoms of abuse therefore
meeting criteria as a diagnostic orphan. These patients may be
experiencing significant functional impairment but fail to receive
treatment due to a lack of dimensionality in diagnosis. The switch
to DSM-5 will include a change in the diagnostic criteria of AUD
such that the abuse and dependence symptoms of the DSM-IV
will be combined. Additionally, the diagnostic criteria of “legal
problems” will be replaced by the symptom “drug craving.” This
move to a singular AUD in DSM-5 is accompanied specification of
severity level (mild, moderate, severe) which is based on the num-
ber of symptoms endorsed. This highlights the growing awareness
of the importance of clinical severity in diagnosis and treatment
planning.
To date, it has been difficult to evaluate AUD severity among
patients as it is challenging to simultaneously capture the multiple
dimensions such as withdrawal, craving, and consequences asso-
ciated with AUD. Thus, a model incorporating these dimensions
would be especially useful in providing a broader conceptual-
ization of AUD severity. To achieve this goal, the present study
validates an AUD severity factor comprised of quantitative scores
from self-report and interview assessments that intentionally mea-
sure the multiple dimensions of clinical impairment observed
across the progression of the disorder. There have been other
efforts to identify latent constructs of AUDs in large epidemio-
logic samples (9) and to develop comprehensive assessments of the
alcohol problem continuum in young adults (10). This study com-
plements those efforts by focusing on a community-based sample
of problem drinkers, by using well-validated clinical scales that
capture multiple dimensions of alcohol use problems and symp-
toms, and by applying a data-driven structural equation modeling
(SEM) approach. Additionally, our efforts to consolidate across
multiple dimensions at a clinical level match well with other stud-
ies that aim to combine clinical variation of alcohol consumption
and related problems at the level of treatment outcomes (11). To
that end, this study seeks to validate an AUD severity model com-
prised of multiple dimensions of AUD phenomenology, such as
diagnostic symptoms, broad-spectrum withdrawal, craving, and
psychosocial consequences and examines it in relation to relevant
clinical constructs, namely alcohol use, affective symptoms, and
motivation for change.
MATERIALS AND METHODS
PARTICIPANTS
Non-treatment seeking problem drinkers were recruited from the
greater Los Angeles area through flyers, print, and online adver-
tisements as part of a larger-scale alcohol administration study
(12). Inclusion criteria consisted of the following: between the
ages of 21 and 65; self-identify as having problems with alcohol;
and consuming a minimum of 48 standard drinks per month.
Exclusionary criteria were: current treatment for alcohol problems,
history of treatment in the 30 days before enrollment, or currently
seeking treatment; current DSM-IV diagnosis of dependence on
any psychoactive substances other than alcohol and nicotine; life-
time DSM-IV diagnosis of schizophrenia, bipolar disorder, or
other psychotic disorder; current use of psychoactive drugs, other
than marijuana, as determined by a positive urine screen; living
with someone who participated in this study; and not having a
drink within 21 days of the phone screening.
PROCEDURES
Interested individuals called in to the laboratory and completed
an initial telephone screening interview in order to assess for eligi-
bility. During this initial screening, participants were asked about
their alcohol use and any diagnosis of a psychiatric disorder. Par-
ticipants who reported they were interested in treatment for their
AUD were excluded from the study. Treatment referrals were pro-
vided to these participants as a later phase of the protocol included
an alcohol administration. Following the telephone screen, eligi-
ble participants were invited to the laboratory in the psychology
department of the University of California Los Angeles for an in-
person session in which they read and signed an informed consent
form and completed a series of questionnaires and interviews.
Participants were compensated $40 for completing the in-person
session. This study was approved by the Institutional Review Board
of the University of California Los Angeles.
MEASURES
Demographic information was collected including age, sex, ethnic-
ity, and education. In addition, multiple interviews and self-report
measures evaluating alcohol use and problems, depression and
anxiety symptomatology, and motivation for change were admin-
istered as described below. All interviews were conducted by bach-
elor’s level interviewees or graduate students under the training
and supervision of a licensed clinical psychologist (LAR).
AUD severity factor
The Structured Clinical Interview for DSM-IV (SCID) (13) was
used to determine eligibility based on diagnostic criteria for AUD
and exclusionary psychiatric disorders. DSM-IV symptoms of
alcohol abuse and alcohol dependence were recorded for a total
of 11 possible symptoms (4 of abuse and 7 of dependence) com-
prising of the indicator variable COUNT. Alcohol withdrawal
was assessed using the Clinical Institute Withdrawal Assessment –
Alcohol Revised [CIWA-AR; (14)]. A total score was tabulated for
each participant to comprise the indicator variable CIWA. The
Penn Alcohol Craving Scale (PACS) is a 5-item, self-report mea-
sure of craving for alcohol during the previous week (15). A total
PACS score was calculated for each participant and included in the
model as the indicator variable PACS. A total score was also cal-
culated from the Alcohol Dependence Scale (ADS) (16), a 25-item
scale that measures alcohol dependence symptoms over the past
12 months. The ADS assesses problems that are relevant for alcohol
dependent drinkers (17, 18). The Drinker Inventory of Conse-
quences [DrInC-2R; (19)] provided a baseline description of the
number and frequency of various drinking consequences. The five
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subscales were summed to provide a single indicator variable of
negative consequences of drinking (DRINC). Thus, the five indi-
cator variables for the AUD severity factor include (i) alcohol abuse
and dependence symptom count (COUNT), (ii) alcohol depen-
dence scale (ADS), (iii) alcohol craving score (PACS), (iv) negative
drinking-related consequences (DRINC), and (v) alcohol with-
drawal score (CIWA). In addition, to investigate the influence of
the categorical DSM-IV diagnostic criteria for alcohol abuse and
dependence, a second model was estimated with the omission of
the alcohol dependence symptom count (COUNT) indicator vari-
able. In brief, the measures used in this study are valid, reliable,
and widely accessible to researchers and clinicians.
Alcohol use
The 30-day timeline follow-back (TLFB) interview (20) was used
to assess drinking behavior. The TLFB is a calendar-assisted self-
report method with high reliability and validity that was used to
obtain a stable and detailed baseline of quantity and frequency
of drinking, including alcohol binges. According to the National
Institute on Alcohol Abuse and Alcoholism (NIAAA) guidelines,
an alcohol binge was defined as consuming four or more drinks
within a given episode for women and five or more drinks for men.
The following indicator variables of alcohol use were derived from
the 30-day TLFB: (i) average drinks per drinking day (DPDD) and
(ii) percent binge drinking days (Binge%).
Depression and anxiety symptoms
To assess for affective symptoms, the Beck Anxiety Inventory (BAI)
and the Beck Depression Inventory, Revised (BDI-II) were used.
The BAI includes 21 items and surveys anxiety symptomatology
including physical and cognitive indicators of anxious mood. The
BDI-II is a 23-item measure of depressive symptomatology, widely
used in psychological research and practice. Therefore, the indica-
tor variables derived for the affective symptoms factor are: (i) BAI
sum score (BAI), and (ii) BDI-II sum score (BDI).
Motivation for change
The Stages of Change Readiness and Treatment Eagerness Scale
(SOCRATES) is a 19-item measure of motivational processes asso-
ciated with the Transtheoretical Model. The SOCRATES has been
shown to be a valid and reliable measure of readiness for change
(21). The following subscales of the SOCRATES were used as indi-
cator variables for the motivation factor: (i) recognition of alcohol-
related problems (RECOG), (ii) uncertainty about drinking
(AMBIV), and (iii) taking action to change drinking (STEPS).
DATA ANALYTIC PLAN – STRUCTURAL EQUATION MODELING
A SEM approach was used to (a) verify the latent factor structure
of the indices of AUD severity, comprised of the indicators vari-
ables: PACS, COUNT, CIWA, DRINC, and ADS, all of which are
described previously (and was tested both with and without the
count indicator variable); and (b) test the relationship between
the AUD severity factor and measures of alcohol use, affective
symptoms, and motivation to change drinking behavior. Further,
it was hypothesized that there would be significant inter-factor
correlations between the three validation constructs (i.e., alcohol
use, affective symptoms, and motivation for change), hence inter-
factor covariances were estimated between these domains. The
latent constructs included observed variables as described in the
measures section (AUD Severity,Alcohol Use,Affective Symptoms,
and Motivation to Change). Variances for independent latent con-
structs were fixed to one with all indicator paths freely estimated.
The variance for the AUD severity construct was freely estimated
with the ADS path coefficient set to one. All errors were freely esti-
mated. Maximum likelihood modeling analyses were conducted
on the raw data using the EQS version 6.1 for Windows SEM
program (22). Robust statistical estimates are reported due to
the non-normal distribution of the alcohol indicator variables.
Statistical model fit was assessed with the Satorra–Bentler scaled
chi-squared fit index (23). A relative estimate (ratio of chi-square
to degrees of freedom) was also calculated, as the use of the chi-
squared likelihood ratio to assess the model fit has been deemed
unsatisfactory for numerous reasons (24). Values <2 on the rela-
tive chi-square indicate adequate model fit (25). Descriptive model
fit was assessed with the robust versions of the comparative fit
index [CFI; (26)] and the root mean square error of approxima-
tion [RMSEA; (27)]. Both the CFI and the RMSEA are sensitive to
model misspecifications and are minimally affected by sample size
(28). The CFI ranges from 0 to 1, with values above 0.90 indicating
acceptable fit (26). The RMSEA ranges from 0 to 8, where fit val-
ues <0.05 indicate close fit and values <0.10 indicate reasonable
fit (29).
RESULTS
DESCRIPTIVE STATISTICS
A total of 295 participants completed the in-person assessment
battery. Six subjects were removed from the analyses for psychi-
atric disorders as determined by the SCID, and 11 were excluded
because of missing data on one or more of the measures, leaving a
total of 283 subjects (75 women, 205 men). Of these 283 subjects,
71.86% met DSM-IV criteria for alcohol dependence, 11.83% met
criteria for alcohol abuse only, 12.19% were diagnostic orphans,
and 4.3% did not endorse any symptoms of either alcohol abuse or
dependence. Means, standard deviations, and correlations across
all model variables are presented in Table 1. Depression and anx-
iety disorders were not evaluated using a diagnostic interview;
however symptomatology was self-reported via the BDI-II and
BAI measures. Clinical cut-off scores were assessed to determine
severity of mood and affective symptoms (30, 31). On the BDI-
II, 33% reported in the minimal range (0–13), 10% scored in the
mild range (14–19), 32% scored in the moderate range (20–28),
and 25% reported in the severe range (29–63). For self-reported
anxiety, 29% reported in the minimal range (0–7), 15% scored in
the mild range (8–15), 24% reported moderate symptoms (16–25),
and 31% scored in the severe range (26–63).
SEMMODEL RESULTS
The model was found to fit well descriptively (CFI= 0.960,
RMSEA= 0.064) and relatively well statistically [S–B scaledχ2 (48,
n= 283)= 103.73; relative χ2= 2.16]. The final estimated model,
with standardized path coefficients, is presented in Figure 1. The
Alcohol Use, Motivation, and Affective Symptoms paths accounted
for 68% of the variance in AUD severity. The following results are
based on the final model with the standard significance threshold
at p< 0.05.
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Table 1 | Means, standard deviation (SD), and correlations for all observed model parameters.
Mean SD 1 2 3 4 5 6 7 8 9 10 11 12
1. ADS 40.25 7.31 1
2. PACS 17.92 6.61 0.50* 1
3. COUNT 5.23 2.81 0.48* 0.35* 1
4. DRINC 40.9 22.12 0.65* 0.52* 0.54* 1
5. CIWA 5.66 6.92 0.23* 0.27* 0.30* 0.23* 1
6. STEPS 2.8 0.93 0.24* 0.16* 0.28* 0.35* 0.09 1
7. RECOG 2.72 0.92 0.48* 0.48* 0.51* 0.68* 0.21* 0.57* 1
8. AMBIV 3.09 0.92 0.44* 0.44* 0.46* 0.58* 0.15* 0.61* 0.80* 1
9. BAI 18.82 12.99 0.29* 0.29* 0.04 0.28* 0.05 0.07 0.23* 0.13* 1
10. BDI 20.56 12.04 0.23* 0.32* 0.06 0.27* 0.07 0.1 0.24* 0.17* 0.83* 1
11. DPDD 7.08 4.66 0.26* 0.26* 0.22* 0.20* 0.22* 0.05 0.20* 0.17* 0.03 0.002 1
12. BINGE% 0.66 0.3 0.33* 0.22* 0.36* 0.33* 0.25* 0.11 0.31* 0.28* 0.02 −0.004 0.62 1
*p<0.05. ADS, alcohol dependence scale; PACS, alcohol craving score; COUNT, alcohol dependence and abuse symptom count; DRINC, negative drinking-related
consequences; CIWA, alcohol withdrawal score; STEPS, taking action to change drinking; RECOG, recognition of alcohol-related problems; AMBIV, uncertainty about
drinking; BAI, anxiety symptoms; BDI, depressive symptoms; DPDD, drinks per drinking days; BINGE%, percent binge drinking days.
FIGURE 1 |The final estimated model with standardized path
coefficients (ß). The following results are based on the final model with the
standard significance threshold at p<0.05.
Importantly, the AUD severity indicator variables, COUNT
(β= 0.647), CIWA (β= 0.313), PACS (β= 0.639), DRINC
(β= 0.860), and ADS (β= 0.737), were all found to load signif-
icantly onto the AUD severity latent construct, suggesting that all
indicators are explaining variance from the same construct. The
affect symptomatology indicator variables, BDI (β= 0.923) and
BAI (β= 0.902), loaded significantly onto the Affective Symptoms
factor. Additionally, DPDD (β= 0.648) and percent binge drink-
ing days (Binge%; β= 0.967) loaded significantly onto the Alcohol
Use factor and the three indicator variables on the Motivation fac-
tor loaded significantly (Steps, β= 0.614; Recognition, β= 0.941;
Ambivalence, β= 0.860).
As expected, the path from Alcohol Use to AUD severity was
found to be statistically significant (β= 0.206), such that greater
AUD severity was associated with higher levels of alcohol use.
The path from Affective Symptoms to AUD severity was found to
be significant (β= 0.167) as well as the path from Motivation to
AUD severity (β= 0.674). The relationships were such that greater
AUD severity predicted increased anxiety/depression symptoms as
well as greater motivation for change. There was a statistically
significant and positive inter-factor correlation between Affec-
tive Symptoms and Motivation (r = 0.257) and between Alcohol
Use and Motivation (r = 0.335), such that individuals report-
ing greater anxiety/depressive symptoms as well as those who
drank more heavily endorsed higher motivation to change their
drinking. However, the relationship between Alcohol Use and
Affective Symptoms was not found to be statistically significant
(r = 0.020).
To investigate the influence of the 12 subjects who did
not endorse any AUD symptoms as assessed by the SCID, the
model was re-estimated with these subjects removed from the
analysis and was found to be virtually identical to the orig-
inal model [CFI= 0.956, RMSEA= 0.067; S–B scaled χ2 (48,
n= 271)= 105.40; relative χ2= 2.20]. Further, to investigate the
possibility of gender differences, a group analysis on the original
model was conducted by constraining all paths in the model to be
equal across gender. The Lagrange multiplier test, used to test the
gender hypothesis in a maximum likelihood framework whereby
the hypothesis being tested is expressed as one or more constraints
on the values of parameters (32), revealed two constrained paths
to be released. These include the paths between BAI and Affective
Symptoms (χ2= 8.26, p< 0.05) as well as between BDI and Affec-
tive Symptoms (χ2= 5.07, p< 0.05), suggesting that influence of
the BAI and BDI on the Affective Symptoms factor in the context
of this model differ between genders.
The second model which excluded the symptom count indi-
cator variable (COUNT) from the AUD severity factor resulted
in estimates that were largely equivalent to the original model,
such that the remaining alcohol severity indices loaded signifi-
cantly onto the severity factor. The second model was also found to
fit well descriptively (CFI= 0.969, RMSEA= 0.064) and relatively
well statistically [S–B scaled χ2 (35, n= 283)= 76.13; relative
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χ2= 2.17]. This suggests that a meaningful AUD severity factor
may be obtained in the absence of diagnostic data (i.e., symptom
count), which is relevant in the context of practicality in a clinical
setting.
DISCUSSION
This study sought to evaluate and validate an AUD severity factor
by assessing the influence of various indices of AUD and test-
ing the factor’s relationship to alcohol use, motivation for change,
and affective symptoms using a SEM approach. The AUD sever-
ity factor is comprised of quantitative scores from self-report
and interview assessments that intentionally measure the multi-
ple dimensions and variability of impairment observed across the
progression of the disorder. Additionally, the AUD severity factor
combines all 11 symptoms of AUD into a single variable (COUNT)
which eliminates the “diagnostic orphan” category. Although each
indicator variable captured different aspects of AUD, all the AUD
severity indicator variables loaded significantly onto a single fac-
tor, and together, greater AUD severity was associated with greater
alcohol use, increased affective symptoms, and higher motivation
to change; thus validating the construct’s utility in clinical settings
and in research.
Neurobiological theory points to the importance of assessing
the progression of AUD as the various stages of severity are asso-
ciated with different outcomes. For example, the persistence of
the psychomotor sensitization (i.e., incentive salience) observed in
severely dependent preclinical samples (5) could help explain why
some individuals with alcohol dependence are more susceptible to
cue-induced relapse than others. In addition, the neurobiological
theories supported by neuroimaging studies of addiction suggest
that treatment response may depend,at least in part,on the severity
of addiction. As an example, if greater alcohol dependence severity
is in fact accompanied by the shift to more striatal driven habitual
behavior, treatments targeting cognitive control over one’s drug
use may prove futile.
Currently, evidence-based treatments for alcohol disorders
largely rely on the DSM-IV categorical clinical diagnosis of abuse
and dependence. However, the field is moving toward a broader
understanding of alcohol disorders as reflected by the ongoing
efforts to change the categorical DSM system to a dimensional
system (33) where individuals diagnosed with an AUD will be
rated on a severity scale ranging from mild to severe (dsm5.org).
The decision to include a singular AUD diagnosis in DSM-5 repre-
sents a shift from the previous distinction between Alcohol Abuse
and Dependence in DSM-IV. This change is founded on an overall
goal of simplifying the diagnostic process for clinicians and a size-
able amount of research suggesting that substance use disorders
are more adequately represented by a continuum of severity (34).
Further, under this new system, those deemed diagnostic orphans
based on DSM-IV criteria may meet for a mild AUD if two symp-
toms are endorsed. Interestingly, however, removal of the DSM-IV
count variable from the AUD severity factor did not alter the rela-
tionships in the present study model or the overall model fit. This
finding implies that the categorical assessment of DSM-IV alcohol
abuse and dependence symptoms (together roughly equating to
the DSM-5 criteria of AUD) provides little information beyond
what is measured by the self-report indices. This is relevant for
clinical practice, as the assessment of DSM-IV, and soon to be
DSM-5, symptomatology requires a lengthy diagnostic interview
that must be administered by trained staff. Thus, it is promising
that quantitative indices of severity can be derived from self-report
data and in the absence of diagnostic data.
The variability in AUDs phenomenology has challenged
researchers and clinicians to generate personalized treatments that
take into account specific clinical profiles (8). These efforts have
been successful in studying response to medications for AUD
based on individuals’ genetic make-up (35, 36). As the field awaits
improvements to make available genetic testing to guide treatment,
having instruments that facilitate the evaluation of AUD severity
offer several advantages that may improve the efficacy of evidence-
based treatments. Administering and scoring these measures may
prove cost effective as clinicians may use the information on AUD
severity to determine whether patients should undergo a detoxi-
fication program, would benefit from inpatient treatment, or are
able to comply with outpatient programs. Similarly, information
on AUD severity may also guide clinician’s judgment regarding
recommendations for medication for AUDs as studies have shown
that certain treatment work better for more or less severe patients
[e.g., quetiapine for high severity, very heavy drinkers; (37)]. In
brief, information on AUD severity can improve treatment efficacy
by guiding clinician’s decision processes based on empirical data.
Of note, alcohol use per se, was not included as a indicator vari-
able of the severity factor as the goal of this paper was to validate
and extend the AUD severity factor previously developed by our
research team (12, 38). We considered testing alcohol use as an
indicator but decided against it as the factor loadings of the clin-
ical scales selected are much higher than the correlation between
alcohol use and the AUD severity factor.
This study must be interpreted in light of its strengths and
weaknesses. This was a cross-sectional examination of problem
drinkers, thereby precluding causal inferences about the progres-
sion of the disorder within individual subjects and about the
relationships between AUD severity and outcome variables. The
exclusion of treatment-seeking individuals, those who met crite-
ria for a lifetime DSM-IV diagnosis of psychiatric disorders, and
current use of psychoactive drugs, limits the generalizability of
the findings. However, as this was part of a larger-scale alcohol
administration study (12) the exclusionary criteria were designed
with safety and ethical concerns in mind. Additionally, although
considered large for the nature of the sample, the sample size is not
sufficient for further in-depth inquiry into sample characteristics
such as the influence of ethnicity within the specified SEM model.
Future studies might address these limitations by recruiting larger
samples within a longitudinal framework.
In summary, this study validated an AUD severity factor in
relation to alcohol use, mood symptomatology, and motivation
to change drinking behavior in a well-characterized community
sample of individuals with AUD. Ultimately, the goal is for the
AUD severity factor to be tested in biologically based models, such
as in neuroimaging (38, 39) and to be utilized by clinicians in order
to provide services that more effectively target patient’s needs. The
successful development and validation of an AUD severity scale
can be used to develop tailored treatment plans for alcohol depen-
dent patients at various stages of the disorder. Likewise, capturing
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AUD severity has broad implications for research,as it will facilitate
the application of clinical neuroscience approaches to AUDs.
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